Therapeutic drug monitoring/toxicology (TDM/tox) is a growth area for the clinical lab, and this 3-part series examines three distinct areas of medicine in which TDM/toxicology laboratories can potentially expand their services.
The number of pain management clinics and programs are increasing in the U.S., and many of them are looking for laboratory services that fit their needs. The first webinar is this series will examine the lab’s role in supporting these clinics.
The second webinar in the series examines how the lab can support a very different medical specialty – the transplant service. In hospitals and health systems that perform transplants or monitor transplant patients on immunosuppressant drugs, there is a critical need for timely and consistent therapeutic drug monitoring. During this webinar, an expert in the field will discuss the advantages and disadvantages of using immunoassay versus tandem mass spectrometry to monitor patients on immunosuppressive therapy.
A different class of drug testing will be discussed during the third webinar in the series, which focuses on how to detect newer drugs of abuse, such as synthetic cannabinoids.
The Lab’s Role in Pain Management
Catherine Hammett-Stabler, PhD, Professor, Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC
An Update on Immunosuppressant Testing
James Ritchie, PhD, Professor, Pathology and Laboratory Medicine, Emory University School of Medicine, Associate Director, Core and Toxicology Laboratories, Emory University Hospital, and Director. Core Laboratory, Emory Crawford Long Hospital, Atlanta, GAM
Toxicological Testing in the Clinical Lab: Balancing Current Needs, Clinical Expectations and Reality
Robert Middleburg, PhD, Vice President, Quality Assurance, Laboratory Director, and Forensic Toxicologist, NMS Labs, Willow Grove, PA